BRCA2 and neoplasm: Genetic testing detected double pathogenic nonsense germline mutations in BRCA1 c.188T>A (p.L63X) and in BRCA2 c.6922A>T (p.K2308X), which were identical to the variants detected in tumor (Table 3).